These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32216868)

  • 1.
    Pellissery AJ; Vinayamohan PG; Venkitanarayanan K
    J Med Microbiol; 2020 Apr; 69(4):631-639. PubMed ID: 32216868
    [No Abstract]   [Full Text] [Related]  

  • 2. Carvacrol reduces Clostridium difficile sporulation and spore outgrowth in vitro.
    Mooyottu S; Flock G; Venkitanarayanan K
    J Med Microbiol; 2017 Aug; 66(8):1229-1234. PubMed ID: 28786786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro efficacy of sodium selenite in reducing toxin production, spore outgrowth and antibiotic resistance in hypervirulent Clostridium difficile.
    Pellissery AJ; Vinayamohan PG; Yin HB; Mooyottu S; Venkitanarayanan K
    J Med Microbiol; 2019 Jul; 68(7):1118-1128. PubMed ID: 31172910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strain-Dependent RstA Regulation of Clostridioides difficile Toxin Production and Sporulation.
    Edwards AN; Krall EG; McBride SM
    J Bacteriol; 2020 Jan; 202(2):. PubMed ID: 31659010
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Zhu D; Sorg JA; Sun X
    Front Cell Infect Microbiol; 2018; 8():29. PubMed ID: 29473021
    [No Abstract]   [Full Text] [Related]  

  • 6. Sub-lethal doses of surotomycin and vancomycin have similar effects on Clostridium difficile virulence factor production in vitro.
    Aldape MJ; Rice SN; Field KP; Bryant AE; Stevens DL
    J Med Microbiol; 2018 Dec; 67(12):1689-1697. PubMed ID: 30307842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Dual-Fluorescent-Reporter System in Clostridioides difficile Reveals a Division of Labor between Virulence and Transmission Gene Expression.
    Donnelly ML; Shrestha S; Ribis JW; Kuhn P; Krasilnikov M; Alves Feliciano C; Shen A
    mSphere; 2022 Jun; 7(3):e0013222. PubMed ID: 35638354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of relapsing Clostridium difficile infections do not correlate with virulence-, spore- and vegetative cell-associated phenotypes.
    Plaza-Garrido Á; Miranda-Cárdenas C; Castro-Córdova P; Olguín-Araneda V; Cofré-Araneda G; Hernández-Rocha C; Carman R; Ibáñez P; Fawley WN; Wilcox MH; Gil F; Calderón IL; Fuentes JA; Guzmán-Durán AM; Alvarez-Lobos M; Paredes-Sabja D
    Anaerobe; 2015 Dec; 36():30-8. PubMed ID: 26403333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fidaxomicin reduces early toxin A and B production and sporulation in Clostridium difficilein vitro.
    Aldape MJ; Packham AE; Heeney DD; Rice SN; Bryant AE; Stevens DL
    J Med Microbiol; 2017 Oct; 66(10):1393-1399. PubMed ID: 28893366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Phosphotransfer Protein CD1492 Represses Sporulation Initiation in Clostridium difficile.
    Childress KO; Edwards AN; Nawrocki KL; Anderson SE; Woods EC; McBride SM
    Infect Immun; 2016 Dec; 84(12):3434-3444. PubMed ID: 27647869
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Coullon H; Rifflet A; Wheeler R; Janoir C; Boneca IG; Candela T
    J Biol Chem; 2018 Nov; 293(47):18040-18054. PubMed ID: 30266804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tigecycline suppresses toxin A and B production and sporulation in Clostridium difficile.
    Aldape MJ; Heeney DD; Bryant AE; Stevens DL
    J Antimicrob Chemother; 2015 Jan; 70(1):153-9. PubMed ID: 25151204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High sporulation and overexpression of virulence factors in biofilms and reduced susceptibility to vancomycin and linezolid in recurrent Clostridium [Clostridioides] difficile infection isolates.
    Tijerina-Rodríguez L; Villarreal-Treviño L; Baines SD; Morfín-Otero R; Camacho-Ortíz A; Flores-Treviño S; Maldonado-Garza H; Rodríguez-Noriega E; Garza-González E
    PLoS One; 2019; 14(7):e0220671. PubMed ID: 31365590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Fidaxomicin with C. difficile Spores: Effects of Persistence on Subsequent Spore Recovery, Outgrowth and Toxin Production.
    Chilton CH; Crowther GS; Ashwin H; Longshaw CM; Wilcox MH
    PLoS One; 2016; 11(8):e0161200. PubMed ID: 27556739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pH-responsive SmrR-SmrT system modulates
    Wetzel D; Carter ZA; Monteiro MP; Edwards AN; Scharer CD; McBride SM
    Infect Immun; 2024 Mar; 92(3):e0046123. PubMed ID: 38345371
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathogenicity Locus, Core Genome, and Accessory Gene Contributions to
    Lewis BB; Carter RA; Ling L; Leiner I; Taur Y; Kamboj M; Dubberke ER; Xavier J; Pamer EG
    mBio; 2017 Aug; 8(4):. PubMed ID: 28790208
    [No Abstract]   [Full Text] [Related]  

  • 17. Clostridium difficile and the disease it causes.
    Norén T
    Methods Mol Biol; 2010; 646():9-35. PubMed ID: 20597000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drivers of Clostridioides difficile hypervirulent ribotype 027 spore germination, vegetative cell growth and toxin production in vitro.
    Yuille S; Mackay WG; Morrison DJ; Tedford MC
    Clin Microbiol Infect; 2020 Jul; 26(7):941.e1-941.e7. PubMed ID: 31715298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equol inhibits growth and spore formation of Clostridioides difficile.
    Tanaka Y; Kimura S; Ishii Y; Tateda K
    J Appl Microbiol; 2019 Sep; 127(3):932-940. PubMed ID: 31211883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. .Clostridioides difficile.
    Sandhu BK; McBride SM
    Trends Microbiol; 2018 Dec; 26(12):1049-1050. PubMed ID: 30297117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.